TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

CSS LLC/IL's Holding History (CIK: 0001103646)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 2,045,000 Value ($000) $1,948 Avg Close Range
Q3 2024
Shares 3,500,000 Value ($000) $3,038 Avg Close Range
Q2 2024
Shares 1,000,000 Value ($000) $648 Avg Close Range
Q1 2023
Shares 8,178,000 Value ($000) $8,039 Avg Close Range
Q4 2022
Shares 5,178,000 Value ($000) $4,711 Avg Close Range
Q2 2022
Shares 1,750,000 Value ($000) $1,762 Avg Close Range